MiR-210 regulates the interaction between pancreatic cancer cells and stellate cells

Biochemical and Biophysical Research Communications

Volumn 437, Issue 3, 2013, Pages 433-439

  Takikawa, Tetsuya ^a   Masamune, Atsushi ^a   Hamada, Shin ^a   Nakano, Eriko ^a   Yoshida, Naoki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibrosis; MicroRNA; Pancreatic cancer; Pancreatitis; Stroma

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 210; REACTIVE OXYGEN METABOLITE; VIMENTIN; WORTMANNIN;

ARTICLE; CANCER PROGNOSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR MICROENVIRONMENT; UPREGULATION;

4′, 6-DIAMIDINO-2-PHENYLINODOLE; 5-BROMO-2′-DEOXYURIDINE; BRDU; CONDITIONED MEDIUM OF HPSC21-S/T CELLS; DAPI; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HIF; HYPOXIA-INDUCIBLE FACTOR; MICRO RNA; MICRORNA; MIRNA; OD; OPTICAL DENSITY; PANCREATIC CANCER; PANCREATIC STELLATE CELLS; PANCREATITIS; PSC-CM; PSCS; STROMA;

ANOXIA; CELL COMMUNICATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COCULTURE TECHNIQUES; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS;

EID: 84880956327     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.097     Document Type: Article

References (35)

1. Brand R.E., Tempero M.A. Pancreatic cancer. Curr. Opin. Oncol. 1998, 10:362-366.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J. Clin. 2006, 56:106-130.
3. Hidalgo M. Pancreatic cancer. N. Engl. J. Med. 2010, 362:1605-1617.
4. Apte M.V., Park S., Phillips P.A., et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004, 29:179-187.
5. Hwang R.F., Moore T., Arumugam T., et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008, 68:918-926.
6. Masamune A., Shimosegawa T. Signal transduction in pancreatic stellate cells. J. Gastroenterol. 2009, 44:249-260.
7. Masamune A., Watanabe T., Kikuta K., et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 2009, 7:S48-54.
8. Erkan M., Adler G., Apte M.V., et al. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012, 61:172-178.
9. Masamune A., Shimosegawa T. Pancreatic stellate cells -multi-functional cells in the pancreas. Pancreatology 2013, 13:102-105.
10. Apte M.V., Wilson J.S., Lugea A., et al. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology 2013, 144:1210-1219.
11. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
12. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
13. Szafranska A.E., Davison T.S., John J., et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452.
14. Lee E.J., Gusev Y., Jiang J., et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 2007, 120:1046-1054.
15. Wang J., Chen J., Chang P., et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res (Phila) 2009, 2:807-813.
16. Greither T., Grochola L.F., Udelnow A., et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 2010, 126:73-80.
17. Papaconstantinou I.G., Manta A., Gazouli M., et al. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas 2013, 42:67-71.
18. Hamada S., Masamune A., Takikawa T., et al. Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2012, 421:349-354.
19. Kikuta K., Masamune A., Hamada S., et al. Pancreatic stellate cells reduce insulin expression and induce apoptosis in pancreatic β-cells. Biochem. Biophys. Res. Commun. 2013, 433:292-297.
20. Chan Y.C., Banerjee J., Choi S.Y., et al. MiR-210: the master hypoxamir. Microcirculation 2012, 19:215-223.
21. Huang X., Ding L., Bennewith K.L., et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 2009, 35:856-867.
22. Ivan M., Harris A.L., Martelli F., et al. Hypoxia response and microRNAs: no longer two separate worlds. J. Cell Mol. Med. 2008, 12:1426-1431.
23. Fasanaro P., Greco S., Lorenzi M., et al. An integrated approach for experimental target identification of hypoxia-induced miR-210. J. Biol. Chem. 2009, 284:35134-35143.
24. Koong A.C., Mehta V.K., Le Q.T., et al. Pancreatic tumors show high levels of hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48:919-922.
25. Masamune A., Kikuta K., Watanabe T., et al. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G709-G717.
26. Mutharasan R.K., Nagpal V., Ichikawa Y., et al. MicroRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1519-H1530.
27. Kim J.H., Park S.G., Song S.Y., et al. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis. 2013, 11:e588.
28. Kikuta K., Masamune A., Watanabe T., et al. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2010, 403:380-384.
29. Thiery J.P., Acloque H., Huang R.Y., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
30. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
31. Blanco D., Vicent S., Elizegi E., et al. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab. Invest. 2004, 84:999-1012.
32. Bao B., Ali S., Ahmad A., et al. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS ONE 2012, 7:e50165.
33. Olive K.P., Jacobetz M.A., Davidson C.J., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
34. Mantoni T.S., Lunardi S., Al-Assar O., et al. Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. Cancer Res. 2011, 71:3453-3458.
35. Feig C., Gopinathan A., Neesse A., et al. The pancreas cancer microenvironment. Clin. Cancer Res. 2012, 18:4266-4276.